Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 465 of 1,261

  1. US 10448634

    Composition with high antimicrobial activity and low toxicity

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  2. US 10451610

    Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1

    The Board of Regents of the University of Texas System · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  3. US 10450371

    Monoclonal antibody and antigens for diagnosing and treating lung disease and injury

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  4. US 10449191

    Treatment of prostate cancer

    Takeda Pharmaceutical Company Limited · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  5. US 10449171

    Compositions and methods for diagnosis and treatment of metabolic syndrome

    The United States of America, as represented by Secretary of the Navy · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  6. US 10449231

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  7. US 10450382

    Anti-complement C1s antibodies

    Bioverativ USA Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  8. US 10448637

    Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  9. US 10450585

    Delivery methods and compositions for nuclease-mediated genome engineering

    Sangamo Therapeutics, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  10. US 10450565

    Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  11. US 10450384

    Compositions of alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  12. US 10450372

    Anti-thyroglobulin T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  13. US 10450572

    Androgen receptor variant inhibitors and methods of using

    Regents of the University of Minnesota · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  14. US 10450364

    Hyperimmunized egg product for treatment of necrotic enteritis in poultry

    United States of America as represented by the Secretary of the Air Force · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  15. US 10450352

    Engineered polypeptides for antigen delivery

    The Board of Regents of the University of Texas System · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  16. US 10450358

    Platelet-derived growth factor B mutant, preparation method therefor and use thereof

    Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  17. US 10450340

    3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation

    Monopar Therapeutics Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  18. US 10450306

    Isoxazole analogs as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  19. US 10450355

    Lectins and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  20. US 10450280

    Tetrazolones as a carboxylic acid bioisosteres

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  21. US 10450275

    Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain

    The Board of Regents of the University of Texas System · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  22. US 10449321

    Gas delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  23. US 10449254

    Ionic liquids for transdermal drug delivery

    Arizona Board of Regents c/o Northern Arizona University · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  24. US 10449241

    Interferon-β production modulating Listeria strains and methods for using same

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.